Ye Meihua, Guo Zhenying, Xu Jingjing, Jin Yanling, He Xianglei, Ge Minghua
Department of Pathology.
Department of Head and Neck Surgery, Otolaryngology and Head and Neck Center, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College.
Am J Surg Pathol. 2024 Aug 1;48(8):1024-1031. doi: 10.1097/PAS.0000000000002251. Epub 2024 May 22.
Primary squamous cell carcinoma (SCC) of the thyroid and anaplastic thyroid carcinoma (ATC) show significant clinical and histologic overlap. Their biological behaviors are so similar that the fifth WHO updates SCC as a morphologic pattern of ATC rather than a separate entity. However, molecular genomic evidence that determines them as the same histologic type is limited. We aimed to explore whether they belong to the same classification from a molecular-typing perspective.
A cohort enrolled 15 SCCs and 15 ATCs was collected. Whole exome sequencing (WES) and RNA-sequencing were performed to analyze molecular genetic and gene-expression profiles.
Significantly differential-mutant genes were BRAF, DPCR1, PCYOX1L, BRSK2, NRG1, PRR14L, TET1, VAMP4 suggesting differences in mutation level, as well as differences in high-frequency mutated genes, and SCC had a much lower tumor mutation burden than ATC. Mutational co-occurrence and mutual exclusion were less frequent in SCC than in ATC. 2047 differential-express genes were screened, indicating differences in gene expression were extremely strong. In principal component analysis, ATC and SCC could be notably clustered together, respectively, meanwhile they could be explicitly distinguished. Unsupervised clustering analysis validated they can indeed be clearly separated from each other which demonstrated that they may be two distinctive entities.
It is controversial yet SCC is classified as a morphologic pattern of ATC. We revealed that SCC exhibited molecular genetic characteristics distinct from ATC. Although the fifth WHO categorizes them together, this study may provide strong molecular genetic evidence for the next edition of WHO classification that may allow for the separation of thyroid SCC from ATC.
甲状腺原发性鳞状细胞癌(SCC)与未分化甲状腺癌(ATC)在临床和组织学上有显著重叠。它们的生物学行为非常相似,以至于世界卫生组织(WHO)第五版将SCC更新为ATC的一种形态学模式,而非一个独立的实体。然而,将它们确定为同一组织学类型的分子基因组证据有限。我们旨在从分子分型的角度探讨它们是否属于同一分类。
收集了一个包含15例SCC和15例ATC的队列。进行全外显子组测序(WES)和RNA测序以分析分子遗传和基因表达谱。
显著差异突变基因有BRAF、DPCR1、PCYOX1L、BRSK2、NRG1、PRR14L、TET1、VAMP4,提示突变水平存在差异,以及高频突变基因存在差异,且SCC的肿瘤突变负荷远低于ATC。SCC中突变共发生和相互排斥的情况比ATC中少见。筛选出2047个差异表达基因,表明基因表达差异非常大。在主成分分析中,ATC和SCC可分别显著聚类在一起,同时又能明确区分。无监督聚类分析验证了它们确实可以彼此清晰分离,这表明它们可能是两个不同的实体。
SCC被归类为ATC的一种形态学模式,这一点存在争议。我们发现SCC表现出与ATC不同的分子遗传特征。尽管WHO第五版将它们归为一类,但本研究可能为WHO下一版分类提供有力的分子遗传学证据,从而可能将甲状腺SCC与ATC区分开来。